Raymond C. Bergan

Department of Medicine, Northwestern University

Affiliated withNorthwestern University Northwestern University

Research Area

Biography

Raymond C. Bergan has not added Biography.
If you are Raymond C. Bergan and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 30	2013

Other Publications

Article	Year
Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene\| PubMed ID: 12447690	2002
Some aspects of analysis of gene array data. Cancer treatment and research\| PubMed ID: 12613351	2002
An analysis of gene array data related to cell adhesion and prostate cancer. Cancer treatment and research\| PubMed ID: 12613352	2002
p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion. Oncogene\| PubMed ID: 12894225	2003
Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 14652284	2003
Safety and efficacy of weekly oral oltipraz in chronic smokers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 15824161	2005
Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer research\| PubMed ID: 15833883	2005
Renal medullary carcinoma and ABL gene amplification. The Journal of urology\| PubMed ID: 15879768	2005
Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer. Cancer\| PubMed ID: 16615097	2006
Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated prote... Molecular pharmacology\| PubMed ID: 16772519	2006
Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells. Molecular pharmacology\| PubMed ID: 17951357	2008
Associations of serum carotenoid levels with serum insulin-like growth factor-i and insulin-like growth factor binding protein-3 levels in black men and white men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 18086788	2007
The methodology used to measure differential gene expression affects the outcome. Journal of biomolecular techniques : JBT\| PubMed ID: 18166675	2007
Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells. Molecular carcinogenesis\| PubMed ID: 18240292	2008
Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer research\| PubMed ID: 18339885	2008
Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images. Nanomedicine : nanotechnology, biology, and medicine\| PubMed ID: 18567541	2008
MEK4 function, genistein treatment, and invasion of human prostate cancer cells. Journal of the National Cancer Institute\| PubMed ID: 19638505	2009
Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration. Carcinogenesis\| PubMed ID: 19736306	2010
Inhibition of cancer cell invasion and metastasis by genistein. Cancer metastasis reviews\| PubMed ID: 20730632	2010
Endoglin suppresses human prostate cancer metastasis. Clinical & experimental metastasis\| PubMed ID: 20981476	2011
Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression. ACS medicinal chemistry letters\| PubMed ID: 21116437	2010
Endoglin regulates cancer-stromal cell interactions in prostate tumors. Cancer research\| PubMed ID: 21444673	2011
The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21464034	2011
Soy Isoflavone Supplementation for Breast Cancer Risk Reduction: A Randomized Phase II Trial. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 22307566	2012
Crystal structure of a type II dehydroquinate dehydratase-like protein from Bifidobacterium longum. Journal of structural and functional genomics\| PubMed ID: 23539270	2013
Androgen receptor-independent function of FoxA1 in prostate cancer metastasis. Cancer research\| PubMed ID: 23539448	2013
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia. Oral oncology\| PubMed ID: 23845699	2013
Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors. PloS one\| PubMed ID: 23967299	2013